Class information for:
Level 1: PENTOXIFYLLINE//LISOFYLLINE//GUDE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8903 1138 32.1 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3088 1875 PENTOXIFYLLINE//FROSTBITE//BUFLOMEDIL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PENTOXIFYLLINE Author keyword 141 32% 32% 369
2 LISOFYLLINE Author keyword 15 63% 1% 15
3 GUDE Address 3 33% 1% 7
4 GEN VASC SURG TRANSPLANTOL Address 3 60% 0% 3
5 PENTOXIPHYLLINE Author keyword 2 36% 0% 5
6 PENTOXIFYLLINE PTX Author keyword 2 67% 0% 2
7 PENTOXIFYLLINE THERAPEUTIC USE Author keyword 2 67% 0% 2
8 G2 M BLOCK ABROGATION Author keyword 1 100% 0% 2
9 HEMORRHEOLOGIC AGENTS Author keyword 1 50% 0% 2
10 METABOLITE 1 Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PENTOXIFYLLINE 141 32% 32% 369 Search PENTOXIFYLLINE Search PENTOXIFYLLINE
2 LISOFYLLINE 15 63% 1% 15 Search LISOFYLLINE Search LISOFYLLINE
3 PENTOXIPHYLLINE 2 36% 0% 5 Search PENTOXIPHYLLINE Search PENTOXIPHYLLINE
4 PENTOXIFYLLINE PTX 2 67% 0% 2 Search PENTOXIFYLLINE+PTX Search PENTOXIFYLLINE+PTX
5 PENTOXIFYLLINE THERAPEUTIC USE 2 67% 0% 2 Search PENTOXIFYLLINE+THERAPEUTIC+USE Search PENTOXIFYLLINE+THERAPEUTIC+USE
6 G2 M BLOCK ABROGATION 1 100% 0% 2 Search G2+M+BLOCK+ABROGATION Search G2+M+BLOCK+ABROGATION
7 HEMORRHEOLOGIC AGENTS 1 50% 0% 2 Search HEMORRHEOLOGIC+AGENTS Search HEMORRHEOLOGIC+AGENTS
8 METABOLITE 1 1 100% 0% 2 Search METABOLITE+1 Search METABOLITE+1
9 METHYLXANTHINE DERIVATIVES 1 100% 0% 2 Search METHYLXANTHINE+DERIVATIVES Search METHYLXANTHINE+DERIVATIVES
10 PHOSPHODIESTERASE INHIBITORS THERAPEUTIC USE 1 100% 0% 2 Search PHOSPHODIESTERASE+INHIBITORS+THERAPEUTIC+USE Search PHOSPHODIESTERASE+INHIBITORS+THERAPEUTIC+USE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SEPTIC GUINEA PIGS 9 83% 0% 5
2 PHOSPHATIDIC ACID GENERATION 8 100% 0% 5
3 OXPENTIFYLLINE 5 27% 1% 15
4 PHOSPHODIESTERASE INHIBITOR PENTOXIFYLLINE 4 39% 1% 9
5 PERITONITIS MODEL 4 47% 1% 7
6 PREFERENTIAL RADIOSENSITIZATION 4 67% 0% 4
7 ORAL PENTOXIFYLLINE 3 43% 1% 6
8 IMMUNOMODULATING AGENT 3 60% 0% 3
9 MURINE COLON ADENOCARCINOMA 2 67% 0% 2
10 RAT RHABDOMYOSARCOMAS 2 67% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY 1987 601 126 66%
PENTOXIFYLLINE 1994 168 132 51%
Immunological mechanisms of pentoxifylline in chronic heart failure 2009 36 39 44%
Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis 2015 2 28 54%
A Review of the Potential Benefits of Pentoxifylline in Diabetic and Non-Diabetic Proteinuria 2011 8 47 64%
A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity 2013 6 65 48%
Effects of phosphodiesterase inhibition on the inflammatory response after shock: Role of pentoxifylline 2004 40 101 40%
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis 1997 74 148 39%
Pentoxifylline for diabetic kidney disease 2012 5 54 43%
Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates 2011 9 28 36%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GUDE 3 33% 0.6% 7
2 GEN VASC SURG TRANSPLANTOL 3 60% 0.3% 3
3 AGGERTALKLIN 1 50% 0.1% 1
4 ANESTHESIOL CRIT CAR 1 50% 0.1% 1
5 BIOPHARMCEUT 1 50% 0.1% 1
6 CARDIAC VASC SURG UNIT 1 50% 0.1% 1
7 CARDIO NEPHROL 1 50% 0.1% 1
8 EAR NOSE THROAT EDUC 1 50% 0.1% 1
9 NEPHRIT URINARY DIS 1 50% 0.1% 1
10 UFR MED PARIS DENIS DIDEROT 7CLAUDE BERNARD IFR0 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000095383 BUFLOMEDIL//CAS 55837 25 7//CENTROPHENOXINE HYDROCHLORIDE
2 0.0000089848 CLINICAL HEMORHEOLOGY//IST CLIN MED MALATTIE CARDIOVASC//VASCULAR ATHEROSCLEROTIC DISEASE
3 0.0000066834 PATHOLCARDIOVASC//RENAL PROSTANOIDS//MCGUIRE
4 0.0000066516 G2 REPAIR//CHROMATID TYPE ABERRATIONS//G2 M OVERRIDE
5 0.0000062495 L1210 CELL LINE//TCRP1//MOL PHYSIOL GENET
6 0.0000054154 HYPERVOLUMETRIC HEMODILUTION//NEUROL D4 5//HYPERVOLEMIC HEMODILUTION
7 0.0000048772 ANTI INTERFERON GAMMA//INTERFERON INHIBITORS//MECLOMEN
8 0.0000045128 2 DEOXYADENOSINE//MOTILITY STIMULANTS//COMPUTER ASSISTED SPERM MOTION ANALYSIS
9 0.0000034981 ANKLE BRACHIAL INDEX//INTERMITTENT CLAUDICATION//PERIPHERAL ARTERIAL DISEASE
10 0.0000034439 NAFTIDROFURYL//NEBRACETAM//MICROSPHERE EMBOLISM